WO2023122436 - DLL3 BINDING PEPTIDES AND USES THEREOF
National phase entry:
Publication Number
WO/2023/122436
Publication Date
29.06.2023
International Application No.
PCT/US2022/081212
International Filing Date
08.12.2022
Title **
[English]
DLL3 BINDING PEPTIDES AND USES THEREOF
[French]
PEPTIDES DE LIAISON À DLL3 ET LEURS UTILISATIONS
Applicants **
AMGEN INC.
c/o Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320-1799, US
Inventors
BAILIS, Julie
c/o Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320-1799, US
TISO, Sylvie A. M.
c/o Amgen Inc.
One Amgen Center Drive
Thousand Oaks, 91320-1799, US
SALVATI, Mark
c/o Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320-1799, US
Priority Data
63/291,537
20.12.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| Sequence Listing | * |
| International Search Report is established | *
International Searching Authority
USPTO
* * |
| Applicant's Legal Status |
Legal Entity
* * * * * |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1976 | |
| EPO | Filing, Examination | 15797 | |
| Japan | Filing | 562 | |
| South Korea | Filing | 578 | |
| USA | Filing, Examination | 6605 |
Total: 25518 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention disclosed herein is directed to polypeptides that bind to DLL3 protein and uses thereof for the diagnosis and treatment of tumors/cancers.[French]
L'invention divulgue des polypeptides qui se lient à la protéine DLL3 et leurs utilisations pour le diagnostic et le traitement de tumeurs/cancers.